_id
6911bef1ccc777a4e85d62f3
Ticker
GPCR
Name
Structure Therapeutics Inc. American Depositary Shares
Exchange
NASDAQ
Address
601 Gateway Boulevard, South San Francisco, CA, United States, 94080
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://structuretx.com
Description
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, which is in two phase 2 clinical trials for the treatment of obesity, overweight, and related conditions. The company also develops ACCG-2671, which is in preclinical trial to treat obesity; ANPA-0073, an oral small molecule agonist targeting the apelin, which is phase 2 ready for selective weight loss or muscle-sparing weight loss; and LTSE-2578, an antagonist that targets lysophosphatidic acid 1 receptor, a G-protein coupled receptors implicated in responses to tissue injury and pro-fibrotic processes, for the treatment of idiopathic pulmonary fibrosis. In addition, it develops programs, including glucose-dependent insulinotropic polypeptide receptor (GIPR) program, which identified multiple GIPR agonist, dual GLP-1R/GIPR agonist, and GIPR antagonist hits for small molecule GIPR modulation that has the potential to provide a treatment in obesity; and GCG program, which identified multiple GCG receptor (GCGR) agonist and dual GLP-1R/GCGR agonist hits for small molecule GCGR modulation. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Last Close
69.77
Volume
919990
Current Price
65.505
Change
-1.43
Last Updated
2026-01-03T12:51:27.014Z
Image
data:image/webp;base64,UklGRuoJAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSGAGAAANGTVtG7C460sj+h98mPw22+7IsbZ/+9Faa621fvKPQ2uttdYG2WIe/XhXAgvjPagQxiM6igazKNAb3AncGO/ByqLR3hNC09wZLIxH3BHcGG9QGYzXaG+HUKA3GSyMyTuE7RGVwWM26D0ZFOhNCAv0Npb3mOMRlUWjvZ1BYZuDiAmYgEfin5lPQ38EhSqe7k+NFBAS0j8gJVbobxAJEaD0J8LyPM8gyqysv6M76fc44Oee5dkIf4qk4jtBQlIHBRMLKSmY0y8VIn8C3D3H8+nPtL/wW6xMz5SRJ1aIqsUf+ZU2vZCzK0XovMS4+LU+ipIqQYlAZELWs+tjLJSuiL2U6eI7fqr8us5XmUwoKCjZcxVV92Jvoouv6vnHCFeQrBJup9/Um2+8WSGeWV2pyKRW5Upc7LntlMZmL0Nh+hVfFF7gLV6kSd+WKGcNHNnSIi20mbza2R1++BNpSRgzSSVuuf6++BLbVZec5zkRC4iCqjMXGvJnOS+W3E6YxoJjCrMv+JrmNT5scjb7DH63beX+VU4y0iJRNW9nP1T7i+PXe52Ha94QMY1E3JkuN3f18N472XTzJb6rUhmTWmEL7YOftKlcvFy1rWi2cMkEI2vntX54Wh1/3Lvs7X3CY9fOL/jJfutjFnuV9F0h5Vfq+8UR3mb/xv7dXpVGk0rq9ZPx4uC9aHP6pGyPuQ1bACnsa8Eck0pft06LmxJc6DEqcTUP33ISV+/3Dnvr//H56jB/Q2vYqesiv5ZOY8GU2v7I31it0g8kFaah1BqO07LZ31brvfw9XUepLDFw2hXVAiAU7bRv36qad3uJIRi+kumipDc6vHd5YjhPNCPiQYigOQAw9dOwzjeqnmseJWvfX/f7274GgSo4kJgbECh7igChOU316iyTcwHDi7hF6edbf7/PgC/cBudeMZBDXCUGAA2hjg+KJtY6AoFTbKpCWweAqj660FRF3CXWHazETkJdKlEndRxBkmNpuhscOwDwPoRNfXH+bwbAp81xntAugHduYSsLyjIUVB35KiYlAErW1YtN8PNak05XOYfNoDzVgIYUDsMSlFka3zoBgMT2YO9T9O7+qmu1nJzbrRPoAJhGNQGNoMwGoRhth4aiO/t/3a7LLAQTHBGUBjkGyBQ6jCojk0sOsgPT+fzwAzYnlw+7QzFMlgAIA0mcOhTCQ4FVM9Qx2y5o2bb7j7bCZKJBAoohRJWVDMRDKZLzjUsK2gWY9mW+898LQOOivE3HSgMMcKaUFcM5zYUmZZIBrPAFJAEqYih7lt1EFZGEaChlJ5PcB0UhvBtQTmfLEkj5gMrFkb4CBiVNRBaHYk20b8sg5HMaBLiYAFbKk8mjwcVMO0goRTPCcBzlQG4H6FnVD7N7nDWr6l7bL/axUwB2DjYcUrCbOHUJ57keDejbqulmTncxdUFV0ggh5nO0NAsXTc1jwGLuGzMGiE04JmRyI6TSjk3dQ74mIY0D/UQsA1DywiFWRjoCT+ncT/jzwj0ljJV7rVgAtYp44Q6aDiPqxvbtLD6GfZ74ehwaIFBA5hrK+1z5MApaMz6X27ne3OwSjwGRjCIgE76+x0XVrGmUgCBvIEs+0TtoQaPFmI1A2lGYptz5GjoK3JpukPkjFLf9FjRa8FUNfkra9WW8elg5jKpIm3xAK3cXjm5hDRmhjUVhjPncrdfXbTWPgNJwIC0bqlfszhPc3baxeTVMOytuTTZ6WKXN/XWzOuAIEEZmndJVEnpCgZvahmBednFlKJp5qYc5TNcn/c3josR4ufd57TPd6Hz6z9FeNPFVdikuXHFr4qvHy3J5/6SfX9sudUxoyck9OCzhsDXjEMsIIs/NHHbWt5vlpp8frk4TMY1FUajp9Tr5N3v8zoFbnxzdXrZS5KopVugvZ7PZib95bTVLUMJ4CVEjb8msNBWTwkwIJoZU1tOlS7Y63J4mYowLCm/ePTG7XHTHD649uNg/a6AlqYvl+jr7q6unimUCE8ZPlDSydwATJBeFgclxrEunVbM/xyUTE66kalfNsbw8OjrdcPZFdlz2jqnzvil8jAATrqxApHfinGOXXHQKCBXwVVXVDgAIV5pB3eG8oVDP9vbWtWQSIpEurPGnqSAQZVNVx6yqZmQpKEAKpT8BEKAK6iZdV/kigyMGE+FPlbDTLGfD0PynM3bC36NWUDggZAMAADAUAJ0BKkAAQAA+rUidSaYkoyEwFA74wBWJbAC83UF+gansYHe+dd97uMMNtCs28HNAerX0AP7H/gOsf9ADyyfZA/dL9sfaQzFU6cOMfz984b1L7A3Ry/Zn2AP1mV9ViZcCLKOswonUFQJo8QJ4u4aDa5uM49t3kRkQUQZnqMthBY9l8k8P2b2baelXlRSF5oje4xNv7B6nPot7Ok4j+/nRlJoyLitbAXAAAP7yO2PparfOP6toEFeAxk0oF1GTPIMnxDw42M7iKVU7z4ccm2645L2b6Hx1ql4xzYrUnhmTMMuvbYH9xhxuff3rWEiLsWblNRoTrThdOVUZegvB9N+s9sRZWwKKCaHaA7Y9/Vofr4pcrgUHPP1TS0W3xi5uS6D0mLQ3qAgqD8LrIyrAW9sRjiF4jQjJU9xBWpNnwRgHEr6wAPBy86nDyRGVFeyyLQuDMfP7OIy8qwHnrOUf8IkCKnTLwq0eDMp/4M5N88j+MpVt1C0C173XHAr/ky5YAKCgeQFd7T0wMjV2jtIwMk6JPzsGUqphOsCwxCJkXuZpeE+dMBDnjn/0DJKVfP5kUSJd/qQO9axtOk6ybFjDeDklw0bBuMq0qD/TLk8rqhGhRten/JRf/ldw5Yi8QfgUd3p8XSDDWQPlA7WCVkhpnz4aPnZSJsRqhGWHOFS5Z86l1FZZ/Ia5VBl57A9EWxazDm3xSrIQ67U0Uy5PdmYqK4rPnSa2wiy/1l343TlT9+kMQi8X6/iMhiMHpjSGtG6+8Uoxob7QVVk74gc0tWTGheA3pB3YpD2dXMEJhB4tM5dmVj7rDvqjYf3do0lBWXYoPnNippkLEAZrU3tUCDp093FW5v/c/nXHlemZE2/8PkIs6BaLuNV9E8r0NJ6VYnA/4etvonf8rGCHQF1ARTHZJ2UzHJrRqaxnAasthkRn37xoi8fVdryPJ2WIBP8R28R1ulmhemf6ShARiY7d/paE/HnzOWsQ7WPo5Ps4SOMFGwD4dYNnXS6VyW4qG125JHjcQpn/0dfLRV/V7aaRseadzgPOVeRVLpO2Gj4k0rc/9/PmrVayKoFAkY4y6IStjUS+TmzXWYisQUm/pF04vfcQkaLEnpLm2c2+MtBNMAz/7tT9EfUfvCWuxdg/nKFsMCgdhX9AAAA=
Ipo Date
2023-02-03T00:00:00.000Z
Market Cap
4811940864
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.7148578947368421
Sentiment Sources
38
Rating
4.5714
Target Price
99.4286
Strong Buy
8
Buy
6
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
73787000
Operating Income
-73787000
Interest Expense
-
Pretax Income
-65604000
Net Income
-65712000
Eps
-1.123480513634665
Dividends Per Share
-
Shares Outstanding
70639178
Income Tax Expense
108000
EBITDA
-65313000
Operating Margin
-
Total Other Income Expense Net
8183000
Cash
102912000
Short Term Investments
696131000
Receivables
-
Inventories
-
Total Current Assets
814022000
Property Plant Equipment
11538000
Total Assets
832159000
Payables
17796000
Short Term Debt
2802000
Long Term Debt
-
Total Liabilities
62140000
Equity
770019000
Bs_currency_symbol
USD
Depreciation
356000
Change In Working Capital
9512000
Cash From Operations
-50996000
Capital Expenditures
1572000
Cash From Investing
-49319000
Cash From Financing
56203000
Net Change In Cash
-44112000
Cf_currency_symbol
USD
PE
-
PB
4.9756766668484795
ROE
-8.533815399360275
ROA
-7.8965678434049265
FCF
-52568000
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
73787000
Quarters > 0 > income Statement > operating Income
-73787000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-65604000
Quarters > 0 > income Statement > net Income
-65712000
Quarters > 0 > income Statement > eps
-1.123480513634665
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
58489666
Quarters > 0 > income Statement > income Tax Expense
108000
Quarters > 0 > income Statement > EBITDA
-65313000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
8183000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
102912000
Quarters > 0 > balance Sheet > short Term Investments
696131000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
814022000
Quarters > 0 > balance Sheet > property Plant Equipment
11538000
Quarters > 0 > balance Sheet > total Assets
832159000
Quarters > 0 > balance Sheet > payables
17796000
Quarters > 0 > balance Sheet > short Term Debt
2802000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
62140000
Quarters > 0 > balance Sheet > equity
770019000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-65712000
Quarters > 0 > cash Flow > depreciation
356000
Quarters > 0 > cash Flow > change In Working Capital
9512000
Quarters > 0 > cash Flow > cash From Operations
-50996000
Quarters > 0 > cash Flow > capital Expenditures
1572000
Quarters > 0 > cash Flow > cash From Investing
-49319000
Quarters > 0 > cash Flow > cash From Financing
56203000
Quarters > 0 > cash Flow > net Change In Cash
-44112000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.123480513634665
Quarters > 0 > ratios > PB
4.9756766668484795
Quarters > 0 > ratios > ROE
-8.533815399360275
Quarters > 0 > ratios > ROA
-7.8965678434049265
Quarters > 0 > ratios > FCF
-52568000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
853991
Quarters > 1 > income Statement > gross Profit
-853991
Quarters > 1 > income Statement > operating Expenses
70451000
Quarters > 1 > income Statement > operating Income
-70451000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-61522000
Quarters > 1 > income Statement > net Income
-61661000
Quarters > 1 > income Statement > eps
-1.064592157922831
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
57919833
Quarters > 1 > income Statement > income Tax Expense
139000
Quarters > 1 > income Statement > EBITDA
-70160000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
8929000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
147024000
Quarters > 1 > balance Sheet > short Term Investments
639472000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
799298000
Quarters > 1 > balance Sheet > property Plant Equipment
10943000
Quarters > 1 > balance Sheet > total Assets
816443000
Quarters > 1 > balance Sheet > payables
8990000
Quarters > 1 > balance Sheet > short Term Debt
2664000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
44362000
Quarters > 1 > balance Sheet > equity
772081000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-61661000
Quarters > 1 > cash Flow > depreciation
291000
Quarters > 1 > cash Flow > change In Working Capital
3083000
Quarters > 1 > cash Flow > cash From Operations
-54558000
Quarters > 1 > cash Flow > capital Expenditures
232000
Quarters > 1 > cash Flow > cash From Investing
48942000
Quarters > 1 > cash Flow > cash From Financing
517000
Quarters > 1 > cash Flow > net Change In Cash
-5099000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.064592157922831
Quarters > 1 > ratios > PB
4.9140422580856145
Quarters > 1 > ratios > ROE
-7.986338220989767
Quarters > 1 > ratios > ROA
-7.552394962048789
Quarters > 1 > ratios > FCF
-54790000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
686976
Quarters > 2 > income Statement > gross Profit
-686976
Quarters > 2 > income Statement > operating Expenses
56311000
Quarters > 2 > income Statement > operating Income
-56311000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-46735000
Quarters > 2 > income Statement > net Income
-46833000
Quarters > 2 > income Statement > eps
-0.816617262423714
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
57350000
Quarters > 2 > income Statement > income Tax Expense
98000
Quarters > 2 > income Statement > EBITDA
-56037000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
9576000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
152123000
Quarters > 2 > balance Sheet > short Term Investments
684759000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
849622000
Quarters > 2 > balance Sheet > property Plant Equipment
10831000
Quarters > 2 > balance Sheet > total Assets
866549000
Quarters > 2 > balance Sheet > payables
8710000
Quarters > 2 > balance Sheet > short Term Debt
2471000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
41911000
Quarters > 2 > balance Sheet > equity
824638000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-46833000
Quarters > 2 > cash Flow > depreciation
274000
Quarters > 2 > cash Flow > change In Working Capital
-6803000
Quarters > 2 > cash Flow > cash From Operations
-52229000
Quarters > 2 > cash Flow > capital Expenditures
314000
Quarters > 2 > cash Flow > cash From Investing
34033000
Quarters > 2 > cash Flow > cash From Financing
809000
Quarters > 2 > cash Flow > net Change In Cash
-17387000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.816617262423714
Quarters > 2 > ratios > PB
4.5555889372063865
Quarters > 2 > ratios > ROE
-5.679219245293086
Quarters > 2 > ratios > ROA
-5.404541462744749
Quarters > 2 > ratios > FCF
-52543000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
37
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1781326
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
890663
Quarters > 3 > income Statement > operating Expenses
47061000
Quarters > 3 > income Statement > operating Income
-47061000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-36343000
Quarters > 3 > income Statement > net Income
-36479000
Quarters > 3 > income Statement > eps
-0.6367762319548937
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
57287000
Quarters > 3 > income Statement > income Tax Expense
136000
Quarters > 3 > income Statement > EBITDA
-46788000
Quarters > 3 > income Statement > operating Margin
-2641.908331209447
Quarters > 3 > income Statement > total Other Income Expense Net
10718000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
169510000
Quarters > 3 > balance Sheet > short Term Investments
714008000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
891211000
Quarters > 3 > balance Sheet > property Plant Equipment
7013000
Quarters > 3 > balance Sheet > total Assets
903330000
Quarters > 3 > balance Sheet > payables
8024000
Quarters > 3 > balance Sheet > short Term Debt
1698000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
38487000
Quarters > 3 > balance Sheet > equity
864843000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-36479000
Quarters > 3 > cash Flow > depreciation
273000
Quarters > 3 > cash Flow > change In Working Capital
-534000
Quarters > 3 > cash Flow > cash From Operations
-36467000
Quarters > 3 > cash Flow > capital Expenditures
16000
Quarters > 3 > cash Flow > cash From Investing
33232000
Quarters > 3 > cash Flow > cash From Financing
615000
Quarters > 3 > cash Flow > net Change In Cash
-2620000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.6367762319548937
Quarters > 3 > ratios > PB
4.339036027348317
Quarters > 3 > ratios > ROE
-4.217991011085249
Quarters > 3 > ratios > ROA
-4.038280584061195
Quarters > 3 > ratios > FCF
-36483000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-20.48081036261751
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
2598302
Annuals > 0 > income Statement > gross Profit
-2598302
Annuals > 0 > income Statement > operating Expenses
158228000
Annuals > 0 > income Statement > operating Income
-158228000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-122216000
Annuals > 0 > income Statement > net Income
-122526000
Annuals > 0 > income Statement > eps
-2.327577363651906
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
52641000
Annuals > 0 > income Statement > income Tax Expense
310000
Annuals > 0 > income Statement > EBITDA
-157236000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
36012000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
169510000
Annuals > 0 > balance Sheet > short Term Investments
714008000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
891211000
Annuals > 0 > balance Sheet > property Plant Equipment
7013000
Annuals > 0 > balance Sheet > total Assets
903330000
Annuals > 0 > balance Sheet > payables
8024000
Annuals > 0 > balance Sheet > short Term Debt
1698000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
38487000
Annuals > 0 > balance Sheet > equity
864843000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-122526000
Annuals > 0 > cash Flow > depreciation
992000
Annuals > 0 > cash Flow > change In Working Capital
2964000
Annuals > 0 > cash Flow > cash From Operations
-116636000
Annuals > 0 > cash Flow > capital Expenditures
1290000
Annuals > 0 > cash Flow > cash From Investing
-358909000
Annuals > 0 > cash Flow > cash From Financing
515263000
Annuals > 0 > cash Flow > net Change In Cash
39718000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-2.327577363651906
Annuals > 0 > ratios > PB
4.146307387583643
Annuals > 0 > ratios > ROE
-14.167426920261828
Annuals > 0 > ratios > ROA
-13.563813888612136
Annuals > 0 > ratios > FCF
-117926000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
949174
Annuals > 1 > income Statement > gross Profit
-949174
Annuals > 1 > income Statement > operating Expenses
102775000
Annuals > 1 > income Statement > operating Income
-102775000
Annuals > 1 > income Statement > interest Expense
13391000
Annuals > 1 > income Statement > pretax Income
-89384000
Annuals > 1 > income Statement > net Income
-89620000
Annuals > 1 > income Statement > eps
-2.4397680559714696
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
36733000
Annuals > 1 > income Statement > income Tax Expense
236000
Annuals > 1 > income Statement > EBITDA
-102480000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
13391000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
129792000
Annuals > 1 > balance Sheet > short Term Investments
337531000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
473608000
Annuals > 1 > balance Sheet > property Plant Equipment
8364000
Annuals > 1 > balance Sheet > total Assets
482017000
Annuals > 1 > balance Sheet > payables
4742000
Annuals > 1 > balance Sheet > short Term Debt
1440000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
29051000
Annuals > 1 > balance Sheet > equity
452966000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-89620000
Annuals > 1 > cash Flow > depreciation
295000
Annuals > 1 > cash Flow > change In Working Capital
6966000
Annuals > 1 > cash Flow > cash From Operations
-79488000
Annuals > 1 > cash Flow > capital Expenditures
2167000
Annuals > 1 > cash Flow > cash From Investing
-268342000
Annuals > 1 > cash Flow > cash From Financing
451531000
Annuals > 1 > cash Flow > net Change In Cash
103701000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-2.4397680559714696
Annuals > 1 > ratios > PB
5.524149627124332
Annuals > 1 > ratios > ROE
-19.785149437264607
Annuals > 1 > ratios > ROA
-18.592705236537302
Annuals > 1 > ratios > FCF
-81655000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
623258
Annuals > 2 > income Statement > gross Profit
-623258
Annuals > 2 > income Statement > operating Expenses
52561000
Annuals > 2 > income Statement > operating Income
-52561000
Annuals > 2 > income Statement > interest Expense
1534000
Annuals > 2 > income Statement > pretax Income
-51304000
Annuals > 2 > income Statement > net Income
-51321000
Annuals > 2 > income Statement > eps
-1.4026730075434568
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
36588000
Annuals > 2 > income Statement > income Tax Expense
17000
Annuals > 2 > income Statement > EBITDA
-52284000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1257000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
26091000
Annuals > 2 > balance Sheet > short Term Investments
64750000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
93089000
Annuals > 2 > balance Sheet > property Plant Equipment
1293000
Annuals > 2 > balance Sheet > total Assets
97845000
Annuals > 2 > balance Sheet > payables
6009000
Annuals > 2 > balance Sheet > short Term Debt
260000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
212985000
Annuals > 2 > balance Sheet > equity
-115140000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-51321000
Annuals > 2 > cash Flow > depreciation
277000
Annuals > 2 > cash Flow > change In Working Capital
2968000
Annuals > 2 > cash Flow > cash From Operations
-46120000
Annuals > 2 > cash Flow > capital Expenditures
155000
Annuals > 2 > cash Flow > cash From Investing
-62108000
Annuals > 2 > cash Flow > cash From Financing
29014000
Annuals > 2 > cash Flow > net Change In Cash
-79214000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.4026730075434568
Annuals > 2 > ratios > PB
-21.646470036477336
Annuals > 2 > ratios > ROE
44.57269411151641
Annuals > 2 > ratios > ROA
-52.45132607695846
Annuals > 2 > ratios > FCF
-46275000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
266353
Annuals > 3 > income Statement > gross Profit
-266353
Annuals > 3 > income Statement > operating Expenses
37696000
Annuals > 3 > income Statement > operating Income
-37696000
Annuals > 3 > income Statement > interest Expense
122161
Annuals > 3 > income Statement > pretax Income
-37818000
Annuals > 3 > income Statement > net Income
-40008000
Annuals > 3 > income Statement > eps
-1.0934732699245655
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
36588000
Annuals > 3 > income Statement > income Tax Expense
231000
Annuals > 3 > income Statement > EBITDA
-37624000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-122000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
105305000
Annuals > 3 > balance Sheet > short Term Investments
2002000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
109250000
Annuals > 3 > balance Sheet > property Plant Equipment
1794000
Annuals > 3 > balance Sheet > total Assets
111155000
Annuals > 3 > balance Sheet > payables
3484000
Annuals > 3 > balance Sheet > short Term Debt
349000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
175890000
Annuals > 3 > balance Sheet > equity
-64735000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-38049000
Annuals > 3 > cash Flow > depreciation
72000
Annuals > 3 > cash Flow > change In Working Capital
4062000
Annuals > 3 > cash Flow > cash From Operations
-32160000
Annuals > 3 > cash Flow > capital Expenditures
1206000
Annuals > 3 > cash Flow > cash From Investing
17859000
Annuals > 3 > cash Flow > cash From Financing
103254000
Annuals > 3 > cash Flow > net Change In Cash
88953000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.0934732699245655
Annuals > 3 > ratios > PB
-38.50119039159651
Annuals > 3 > ratios > ROE
61.80273422414459
Annuals > 3 > ratios > ROA
-35.99298277180514
Annuals > 3 > ratios > FCF
-33366000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-1.123480513634665
Valuation > metrics > PB
4.9756766668484795
Valuation > final Score
30.243233331515203
Valuation > verdict
65.9% Overvalued
Profitability > metrics > ROE
-8.533815399360275
Profitability > metrics > ROA
-8.072509096805737
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.08069930741968705
Risk > metrics > Interest Coverage
-253.56357388316152
Risk > final Score
-954
Risk > verdict
High
Liquidity > metrics > Current Ratio
39.51946790950578
Liquidity > metrics > Quick Ratio
39.51946790950578
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
30.859577419143854
Prev Valuations > 1
34.44411062793614
Prev Valuations > 2
36.60963972651683
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
27
Prev Risks > 1
36
Prev Risks > 2
42
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:55:24.487Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.37
Earnings History > 0 > eps Estimate
-0.27
Earnings History > 0 > eps Difference
-0.1
Earnings History > 0 > surprise Percent
-37.037
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.89
Earnings History > 1 > eps Estimate
-0.26
Earnings History > 1 > eps Difference
-1.63
Earnings History > 1 > surprise Percent
-626.9231
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-08
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.82
Earnings History > 2 > eps Estimate
-0.25
Earnings History > 2 > eps Difference
-0.57
Earnings History > 2 > surprise Percent
-228
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-27
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.21
Earnings History > 3 > eps Estimate
-0.28
Earnings History > 3 > eps Difference
0.07
Earnings History > 3 > surprise Percent
25
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-14
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.2
Earnings History > 4 > eps Estimate
-0.27
Earnings History > 4 > eps Difference
0.07
Earnings History > 4 > surprise Percent
25.9259
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.18
Earnings History > 5 > eps Estimate
-0.24
Earnings History > 5 > eps Difference
0.06
Earnings History > 5 > surprise Percent
25
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.19
Earnings History > 6 > eps Estimate
-0.21
Earnings History > 6 > eps Difference
0.02
Earnings History > 6 > surprise Percent
9.5238
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-08
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.5316
Earnings History > 7 > eps Estimate
-0.21
Earnings History > 7 > eps Difference
-0.3216
Earnings History > 7 > surprise Percent
-153.1429
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.62
Earnings History > 8 > eps Estimate
-0.29
Earnings History > 8 > eps Difference
-0.33
Earnings History > 8 > surprise Percent
-113.7931
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.6
Earnings History > 9 > eps Estimate
-0.28
Earnings History > 9 > eps Difference
-0.32
Earnings History > 9 > surprise Percent
-114.2857
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.25
Earnings History > 10 > eps Estimate
-0.41
Earnings History > 10 > eps Difference
0.16
Earnings History > 10 > surprise Percent
39.0244
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-1.14
Earnings History > 11 > eps Estimate
-0.82
Earnings History > 11 > eps Difference
-0.32
Earnings History > 11 > surprise Percent
-39.0244
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, which is in two phase 2 clinical trials for the treatment of obesity, overweight, and related conditions. The company also develops ACCG-2671, which is in preclinical trial to treat obesity; ANPA-0073, an oral small molecule agonist targeting the apelin, which is phase 2 ready for selective weight loss or muscle-sparing weight loss; and LTSE-2578, an antagonist that targets lysophosphatidic acid 1 receptor, a G-protein coupled receptors implicated in responses to tissue injury and pro-fibrotic processes, for the treatment of idiopathic pulmonary fibrosis. In addition, it develops programs, including glucose-dependent insulinotropic polypeptide receptor (GIPR) program, which identified multiple GIPR agonist, dual GLP-1R/GIPR agonist, and GIPR antagonist hits for small molecule GIPR modulation that has the potential to provide a treatment in obesity; and GCG program, which identified multiple GCG receptor (GCGR) agonist and dual GLP-1R/GCGR agonist hits for small molecule GCGR modulation. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAssessing Structure Therapeutics (GPCR) Valuation After Genentech Deal And Growing Obesity Pipeline Confidence simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$99.4286
Analyst Picks
Strong Buy
8
Buy
6
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Structure Therapeutics Inc. American Depositary Shares
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.37
EPS Estimate
-0.27
EPS Difference
-0.1
Surprise Percent
-37.037%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.